Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)in Combination With Docetaxel for the Treatment of Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1
A Study of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel and Temozolomide in Treating Patients With Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil
- Status
- TERMINATED
- Phase
- PHASE2
Phase I Trial of Docetaxel With Perifosine
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
- Status
- UNKNOWN
- Phase
- PHASE2
Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone
- Status
- COMPLETED
- Phase
- N/A
Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxel and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.
- Status
- WITHDRAWN
- Phase
- PHASE2
Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2